about
Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer.Non-metastatic castrate-resistant prostate cancer: a call for improved guidance on clinical management.Symptoms and Impacts in Non-Metastatic Castration-Resistant Prostate Cancer: Qualitative Study Findings.Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy.Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells.Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells
P2860
Q36861608-43EC6DF0-D121-4A26-919E-D1E4244755A7Q38779039-A2AC9015-C466-41A1-984E-66667CB70645Q39174720-5F97478F-6D5B-451B-982A-2D4720F7F175Q41636538-4A0520EF-08CF-41D4-B7F4-F9FEF0A24363Q47114438-11FB5BC3-341B-4C74-876D-85FE86F29116Q47602394-751C4071-E094-4A60-A091-A6D4C68B7524Q58572503-D454DDA2-BF14-4E8E-B77A-24D2A9E41B00
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Nonmetastatic castration-resistant prostate cancer.
@en
type
label
Nonmetastatic castration-resistant prostate cancer.
@en
prefLabel
Nonmetastatic castration-resistant prostate cancer.
@en
P2860
P1476
Nonmetastatic castration-resistant prostate cancer.
@en
P2093
Isaac Y Kim
Jun Hyuk Hong
P2860
P304
P356
10.4111/KJU.2014.55.3.153
P577
2014-03-13T00:00:00Z